MedTrace Logo

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

NCT05286034 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000

Last updated 2026-03-27

No results posted yet for this study

Summary

This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.

Conditions

Interventions

BEHAVIORAL

Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms

Non-compliant women those that have not been screened for more than 4 years and living in the disadvantaged areas will be sent screening reminder letters to perform HPV self-sampling (HPVss) test, with access to decision aid tailored to women with lower education attainment and available via Chatbot platforms. ChatBot will deliver information in a responsive, conversational way via text and spoken language in multiple languages through multiple mobile channels.

Sponsors & Collaborators

  • Centre Régional de Coordination des Dépistages des Cancers, centre-Carcassonne

    collaborator UNKNOWN

  • Université de Bretagne Occidentale, Brest-France

    collaborator UNKNOWN

  • International Agency for Research on Cancer

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2026-07-31
Completion
2026-08-18

Countries

  • France

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05286034 on ClinicalTrials.gov